stomatitis

(redirected from amlexanox)
Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Words related to stomatitis

inflammation of the mucous membrane of the mouth

References in periodicals archive ?
Different formulations of amlexanox are currently prescribed to treat asthma in Japan and canker sores in the United States.
A systematic review of 4 double-blind RCTs found that the anti-inflammatory amlexanox 5% paste significantly reduced ulcer size compared with placebo (-1 vs 0 mm on Day 3 and -3 vs -1 mm on Day 5; P<.
Amlexanox oral paste 5% Aphthasol[R] gg Lidocaine Xylocaine[R] aa 2% viscous Triamcinolone Acetonide Kenalog [R] y in Dental Paste Orabase[R] 0.
OraDisc A[TM] is a novel patented mucoadhesive, water-erodible disc incorporating 2mg of amlexanox for the treatment and prevention of aphthous ulcers.
In addition to ULURU's current OraDisc products, amlexanox for the prevention and treatment of canker sores and benzocaine for oral pain, ULURU has prioritized tooth whitening, cough and cold and desensitizing teeth as the lead consumer product developments.
1% - 15 gm (3 supply and safe delivery of - tube - amlexanox 5% w/w - 3 gm (4 supply and safe delivery of syp cough syrup containing minimum ingredient in each 5ml of following: terbutaline+ambroxol - 100 ml (5supply and safe delivery of - tab - cetirizine+ ambroxol - 5+60 mg.
Bridge Technology Group LLC announced today that it has reiterated its BUY recommendation on Access Pharmaceuticals (OTC:AXCS) following AXCS' announcement that it had acquired rights from Block Drug Company to amlexanox for the indication of mucositis.
OTC BB:AXCS) today announced that it has signed a Letter of Intent to license amlexanox 5% paste to Laboratorios Dr.
OTC BB:AXCS) today announced that it has signed a Letter of Intent to license amlexanox 5% paste to Meda AB of Goteborg, Sweden, for Sweden, Finland, Norway, Denmark, Latvia, Estonia, Lithuania and Iceland.
Paladin") to license for the Canadian market amlexanox 5% paste for the treatment of canker sores.
OTC BB:AXCS) today announced that the product license application for amlexanox 5% paste for the treatment of canker sores has been submitted to the UK Medicine Control Agency by Strakan Ltd.
OTC BB:AXCS) today announced that it has signed a binding Letter of Intent with Strakan Limited to license amlexanox 5% paste for the treatment of canker sores for the United Kingdom and Ireland.
These activities are focused on the advancement of the Polymer Platinate AP 5070 into clinical development, developing new dosage forms and line extensions of the approved product amlexanox and developing product candidates from our advanced drug delivery platforms.
OTC/BULLETIN BOARD:AXCS) today announced that it has signed an agreement to license from Block Drug Company the rights to amlexanox oral paste 5% for all markets excluding The United States, Japan and Israel.
Amlexanox oral paste 5% is currently marketed in The United States by Block Drug Company under the trademark Aphthasol(TM).